Survival of patients receiving Gemcitabine and Cisplatin for Advanced Biliary Tract Cancer

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective analysis reveals overall survival outcomes in advanced biliary tract cancer patients, suggesting need for early diagnosis.

Patients with advanced biliary tract cancer showed mean overall survival of 8.7 to 12.2 months with chemotherapy.
The mean overall survival was 8.7 months for intrahepatic cholangiocarcinoma, 12.2 months for extrahepatic cholangiocarcinoma.
Mean overall survival in gallbladder carcinoma was 9.5 months, with no significant variations between cancer types.
ECOG performance status and early diagnosis were identified as critical for improving patient outcomes.

Tohumcuoğlu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark